Preferred Label : lebrikizumab;

MeSH note : anti-interleukin-13 MAb for treatment of asthma;

MeSH hyponym : MILR-1444A; PRO-301444;

Is substance : O;

UNII : U9JLP7V031;

Details


Main resources

You can consult :


https://www.ema.europa.eu/en/medicines/human/EPAR/ebglyss
2024
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
lebrikizumab
lebrikizumab
lebrikizumab
drug approval
europe
dermatitis, atopic
adult
child
adolescent
injections, subcutaneous
risk management
product surveillance, postmarketing
aged
pregnancy
breast feeding
drug interactions
Interleukin-13
drug evaluation, preclinical

---
Nous contacter.
25/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.